<strike id="nltfj"></strike><strike id="nltfj"><dl id="nltfj"><ruby id="nltfj"></ruby></dl></strike>
<strike id="nltfj"><video id="nltfj"></video></strike>
<strike id="nltfj"></strike>
<strike id="nltfj"></strike>
<strike id="nltfj"></strike>
<span id="nltfj"></span>
<span id="nltfj"></span>
<span id="nltfj"><video id="nltfj"></video></span>
<strike id="nltfj"><video id="nltfj"><ruby id="nltfj"></ruby></video></strike>
<strike id="nltfj"></strike>

Areas of Interest (AOI)

Bristol Myers Squibb seeks Independent Research applications across all therapeutic areas.? Our Areas of Interest outline additional criteria to help guide the scientific community.? All concept applications submitted that best align with our interest will be considered & evaluated. Concepts may be submitted outside of the posted AOIs, but the threshold for approval may be relatively high.

The criteria will include, but not be limited to:

  • Specific therapeutic area of interest
  • The type of science we are seeking
  • We may include a specific window of time for all concept applications to be submitted

Competitive Research Grants

The Bristol Myers Squibb Competitive Research Grant process includes the submission of a concept application that meets the required criteria posted. Competitive Research Grants we post will include specific criteria that must be met for your application to be considered.

At this time, there are no competitive research grants available.

Click here?for trademark information on Bristol Myers Squibb products.


Please click on the product name to see the Full U.S. Prescribing Information for ELIQUIS?, EMPLICITI?, NULOJIX?, OPDIVO?, ORENCIA?, SPRYCEL?, YERVOY?, including Boxed WARNINGS for ELIQUIS?, NULOJIX?, and Boxed WARNING for YERVOY? regarding immune-mediated adverse reactions.

Begin a New Application

If interested in a product or an investigational compound not listed